maximum weight loss tirzepatide surmount trials for Obesity: Highlights from the SURMOUNT-1 Trial Semaglutide vs tirzepatide vs retatrutide:

For those in the semaglutide group, the weight-loss trajectory continued to week 65 and then was sustained for the study period through week 208 (10.2% for the semaglutide group, 1.5% for the placebo group

GI irritation Irritation or discomfort in the gastrointestinal tract, which includes the stomach and intestines

Common Lipo-C Questions & Mistakes "It stopped working." More often this is expectation mismatch the injection was never the main driver of weight change

doi:10.1093/toxsci/kfi057

In some instances, it can be dangerous to withdraw without medical support.

Gallbladder-related complications warrant particular attention